BeOne Medicines
ONC
#624
Rank
NZ$64.98 B
Marketcap
NZ$587.28
Share price
1.62%
Change (1 day)
48.81%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: NZ$64.98 Billion

As of February 2026 BeOne Medicines has a market cap of NZ$64.98 Billion. This makes BeOne Medicines the world's 624th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$64.98 B8.88%
2025NZ$59.68 B64.37%
2024NZ$36.31 B16.5%
2023NZ$31.17 B-22.18%
2022NZ$40.05 B-1.55%
2021NZ$40.68 B24.04%
2020NZ$32.80 B116.22%
2019NZ$15.17 B21.77%
2018NZ$12.45 B98.83%
2017NZ$6.26 B260.33%
2016NZ$1.73 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of BeOne Medicines was reported to be:

NZ$64.98 Billion
by Nasdaq info icon info icon
NZ$64.98 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
NZ$1.65 B-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ$34.87 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA